36 related articles for article (PubMed ID: 7198939)
1. High-dose cisplatin for lung cancer.
Bhuchar VK; Lanzotti VJ
Cancer Treat Rep; 1982 Feb; 66(2):375-6. PubMed ID: 7198939
[No Abstract] [Full Text] [Related]
2. Four-day paclitaxel infusion with cisplatin for patients with lung cancer.
Georgiadis MS; Schuler B; Johnson BE
Semin Oncol; 1995 Aug; 22(4 Suppl 9):67-9. PubMed ID: 7544027
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
[TBL] [Abstract][Full Text] [Related]
4. Escalating high-dose epirubicin plus cisplatin in small cell lung cancer with granulocyte-macrophage colony-stimulating factor use when appropriate.
Rosell R; Gómez-Codina J; Anton A; Sánchez JJ; Vadell C
Semin Oncol; 1994 Feb; 21(1 Suppl 1):48-53. PubMed ID: 8153657
[No Abstract] [Full Text] [Related]
5. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Kaira K; Sunaga N; Yanagitani N; Kawata T; Utsugi M; Shimizu K; Ebara T; Kawamura H; Nonaka T; Ishikawa H; Sakurai H; Suga T; Hara K; Hisada T; Ishizuka T; Nakano T; Mori M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):109-14. PubMed ID: 18929446
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue.
Franke UF; Wittwer T; Kaluza M; Albert M; Becker V; Roskos M; Lessel M; Wahlers T
Eur J Cardiothorac Surg; 2004 Oct; 26(4):800-6. PubMed ID: 15450576
[TBL] [Abstract][Full Text] [Related]
7. Results of the phase II EORTC study comparing paclitaxel/cisplatin with teniposide/cisplatin in patients with non-small cell lung cancer. EORTC Lung Cancer Cooperative Group.
Postmus PE; Giaccone G; Debruyne C; Sahmoud T; Splinter TA; van Zandwijk N
Semin Oncol; 1996 Oct; 23(5 Suppl 12):10-3. PubMed ID: 8941404
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
[TBL] [Abstract][Full Text] [Related]
9. [High dose cisplatin combination chemotherapy for advanced breast cancer--a report on 50 cases].
Zhou JC
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):215-7. PubMed ID: 8261870
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer.
Chikamori K; Kishino D; Takigawa N; Hotta K; Nogami N; Kamei H; Kuyama S; Gemba K; Takemoto M; Kanazawa S; Ueoka H; Segawa Y; Takata S; Tabata M; Kiura K; Tanimoto M;
Lung Cancer; 2009 Jul; 65(1):74-9. PubMed ID: 19056143
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of amrubicin hydrochloride and cisplatin in patients previously treated for advanced non-small cell lung cancer.
Ikeda J; Maruyama R; Okamoto T; Shoji F; Wataya H; Ichinose Y
Jpn J Clin Oncol; 2006 Jan; 36(1):12-6. PubMed ID: 16418184
[TBL] [Abstract][Full Text] [Related]
12. Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy.
Huisman C; Biesma B; Postmus PE; Giaccone G; Schramel FM; Smit EF
Br J Cancer; 2001 Nov; 85(10):1456-61. PubMed ID: 11720428
[TBL] [Abstract][Full Text] [Related]
13. Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer.
Thongprasert S; Chewaskulyong B
J Med Assoc Thai; 2004 Oct; 87(10):1162-7. PubMed ID: 15560691
[TBL] [Abstract][Full Text] [Related]
14. High-dose cisplatin and vinblastine plus amifostine for metastatic non-small cell lung cancer.
Schiller JH
Semin Oncol; 1996 Aug; 23(4 Suppl 8):78-82. PubMed ID: 8783672
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced atrial fibrillation.
Menard O; Martinet Y; Lamy P
J Clin Oncol; 1991 Jan; 9(1):192-3. PubMed ID: 1985170
[No Abstract] [Full Text] [Related]
16. Evaluation of cisplatin-lithium interaction.
Pietruszka LJ; Biermann WA; Vlasses PH
Drug Intell Clin Pharm; 1985 Jan; 19(1):31-2. PubMed ID: 4038480
[No Abstract] [Full Text] [Related]
17. Cisplatin and plasma iron levels.
Grau JJ; Estape J; Daniels M; Guzman MC; Santabarbara P
Ann Intern Med; 1985 Jul; 103(1):158-9. PubMed ID: 4039904
[No Abstract] [Full Text] [Related]
18. cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer. II: Clinical effects.
Nakagawa H; Fujita T; Izumimoto S; Miyawaki Y; Kubo S; Nakajima Y; Tsuruzono K; Kodama K; Higashiyama M; Doi O
J Neurooncol; 1993 Apr; 16(1):69-76. PubMed ID: 8410145
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of brain metastases of lung cancer: retrospective analysis of 89 cases.
Nakagawa H; Miyawaki Y; Fujita T; Kubo S; Tokiyoshi K; Tsuruzono K; Kodama K; Higashiyama M; Doi O; Hayakawa T
J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):950-6. PubMed ID: 8057119
[TBL] [Abstract][Full Text] [Related]
20. Vindesine/cisplatin chemotherapy in relapsed or primarily resistant small-cell carcinoma of the lung.
Niederle N; Schütte J; Krischke W; Seeber S; Schmidt CG
Klin Wochenschr; 1984 Aug; 62(16):783-6. PubMed ID: 6090762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
